<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02226302</url>
  </required_header>
  <id_info>
    <org_study_id>FETCH</org_study_id>
    <nct_id>NCT02226302</nct_id>
  </id_info>
  <brief_title>Linking Obesity and Estrogen-responsive Genes in Endometrial Cancer</brief_title>
  <acronym>FETCH</acronym>
  <official_title>Linking Obesity and Estrogen-responsive Genes in Endometrial Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Queensland Centre for Gynaecological Cancer</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Queensland Institute of Medical Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Royal Brisbane and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Queensland Centre for Gynaecological Cancer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective is to develop an organotypic model to assess the effects of obesity on the
      expression and methylation status of estrogen-responsive genes in endometrial cancer. Omental
      fat samples will be removed from participants during surgery and these fat samples will be
      used in laboratory analyses.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 2014</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Identify estrogen-response genes in endometrial cancer</measure>
    <time_frame>Baseline</time_frame>
    <description>Omental fat will be collected from 6 lean patients, 6 obese patients and 4 controls (male patients) and co-cultured with endometrial cancer cell lines</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Examine how expression of estrogen response genes are altered in obesity</measure>
    <time_frame>Baseline</time_frame>
    <description>Compare gene response in tissue from lean and obese individuals</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Endometrial Cancer</condition>
  <arm_group>
    <arm_group_label>Female Group 2</arm_group_label>
    <description>Females with BMI &gt;30 kg/m2 who are having a hysterectomy for benign conditions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Females Group 1</arm_group_label>
    <description>Females with BMI &lt;30 kg/m2 who are having a hysterectomy for benign conditions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Males</arm_group_label>
    <description>2 males with BMI &lt;30 kg/m2 and 2 males with BMI &gt;30 kg/m2</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Omental fat samples will be stored for one year for study purposes. They will not be stored
      for future research
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        12 female patients undergoing surgery for pre-existent conditions will be recruited for
        this study. The groups will include 6 patients with a BMI &lt; 30 kg/m2 and 6 patients with a
        BMI ≥ 35 kg/m2. In addition 4 males patients will be recruited to assess responses from
        patients with low levels of serum estradiol.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-80 years

          -  Any patient having abdominal surgery (Laparoscopic or open technique) for benign
             conditions

          -  Eastern Cooperative Oncology Group (ECOG) performance status 0-2

          -  Patients must have adequate:

          -  Hematologic function: Neutrophils ≥ 1.5 x 109/L and platelets ≥ 100 x 109/L

          -  Renal function: serum creatinine ≤ ULN or estimated glomerular filtration rate (eGFR)
             [CKD-EPI Formula] ≥ 60 mL/min

          -  Hepatic function: serum bilirubin ≤ 1.5 x ULN and AST ≤ 2.5 x ULN and ALT≤ 2.5 x ULN

          -  Physically able to undergo surgery

          -  Written informed consent

        Exclusion Criteria:

          -  Confirmed gynaecological malignancy

          -  Contraindications and/or unfit for Surgery: serious concomitant systemic disorders
             incompatible with the study (at the discretion of the investigator);

          -  Patients who are pregnant or lactating

          -  Serious illness or medical condition but not limited to, ongoing or active infection,
             symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia
             (patients with stable AF are eligible), or psychiatric illness/social situations that
             would limit compliance with study requirements.

          -  Patients with disseminated intra-peritoneal malignancy or suspected ovarian cancer

          -  HIV positive

          -  Previous bariatric surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Donal Brennan</last_name>
    <role>Principal Investigator</role>
    <affiliation>Queensland Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Queen Elizabeth II Jubilee Hospital</name>
      <address>
        <city>Coopers Plains</city>
        <state>Queensland</state>
        <zip>4108</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Brisbane and Women's Hospital</name>
      <address>
        <city>Herston</city>
        <state>Queensland</state>
        <zip>4029</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 11, 2014</study_first_submitted>
  <study_first_submitted_qc>August 25, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 27, 2014</study_first_posted>
  <last_update_submitted>April 30, 2018</last_update_submitted>
  <last_update_submitted_qc>April 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Endometrial cancer</keyword>
  <keyword>Obesity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Endometrial Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Estrogens</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

